These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 24099148)

  • 21. Allergic rhinitis. Outcomes of immunotherapy on symptom control.
    Cook PR
    Otolaryngol Clin North Am; 1998 Feb; 31(1):129-40. PubMed ID: 9530682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subcutaneous and sublingual immunotherapy for allergic rhinitis: what is the evidence?
    Wise SK; Schlosser RJ
    Am J Rhinol Allergy; 2012; 26(1):18-22. PubMed ID: 22391071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statement.
    Bousquet J; Schünemann HJ; Bousquet PJ; Bachert C; Canonica GW; Casale TB; Demoly P; Durham S; Carlsen KH; Malling HJ; Passalacqua G; Simons FE; Anto J; Baena-Cagnani CE; Bergmann KC; Bieber T; Briggs AH; Brozek J; Calderon MA; Dahl R; Devillier P; Gerth van Wijk R; Howarth P; Larenas D; Papadopoulos NG; Schmid-Grendelmeier P; Zuberbier T
    Allergy; 2011 Jun; 66(6):765-74. PubMed ID: 21496059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Sublingual immunotherapy in children with grass pollen induced allergic rhinoconjunctivitis].
    Wolthers OD; Høst A; Frederiksen B; Halken S
    Ugeskr Laeger; 2012 Aug; 174(35):1989-92. PubMed ID: 22929576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparability of subcutaneous and sublingual immunotherapy outcomes in allergic rhinitis clinical trials.
    Calderon MA; Eichel A; Makatsori M; Pfaar O
    Curr Opin Allergy Clin Immunol; 2012 Jun; 12(3):249-56. PubMed ID: 22499145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sublingual immunotherapy in daily medical practice: effectiveness of different treatment schedules - IPD meta-analysis.
    Sieber J; Köberlein J; Mösges R
    Curr Med Res Opin; 2010 Apr; 26(4):925-32. PubMed ID: 20163297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of subcutaneous and sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a meta-analysis-based comparison.
    Di Bona D; Plaia A; Leto-Barone MS; La Piana S; Di Lorenzo G
    J Allergy Clin Immunol; 2012 Nov; 130(5):1097-1107.e2. PubMed ID: 23021885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and tolerability of ultra-Rush (20 minutes) sublingual immunotherapy in patients with allergic rhinitis and/or asthma.
    Gammeri E; Arena A; D'Anneo R; La Grutta S
    Allergol Immunopathol (Madr); 2005; 33(3):142-4. PubMed ID: 15946626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Allergen-specific immunotherapy (hyposensitization). Part 2. Oral, sublingual and nasal application].
    Fuchs T; Klimek L
    HNO; 2000 Feb; 48(2):158-64. PubMed ID: 10663067
    [No Abstract]   [Full Text] [Related]  

  • 30. Changing the route of immunotherapy administration: an 18-year survey in pediatric patients with allergic rhinitis and asthma.
    Pajno GB; Caminiti L; Passalacqua G
    Allergy Asthma Proc; 2013; 34(6):523-6. PubMed ID: 24169060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sublingual immunotherapy for allergic rhinitis and conjunctivitis.
    Passalacqua G; Garelli V; Sclifò F; Canonica GW
    Immunotherapy; 2013 Mar; 5(3):257-64. PubMed ID: 23444955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systematic reviews of sublingual immunotherapy (SLIT).
    Radulovic S; Wilson D; Calderon M; Durham S
    Allergy; 2011 Jun; 66(6):740-52. PubMed ID: 21443635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sublingual immunotherapy for allergic rhinitis: an update.
    Passalacqua G; Compalati E; Canonica GW
    Curr Opin Otolaryngol Head Neck Surg; 2011 Feb; 19(1):43-7. PubMed ID: 21102336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adult and pediatric clinical trials of sublingual immunotherapy in the USA.
    Park D; Daher N; Blaiss MS
    Expert Rev Clin Immunol; 2012 Aug; 8(6):557-64. PubMed ID: 22992150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized controlled trial of high-dose sublingual immunotherapy to treat seasonal allergic rhinitis.
    Smith H; White P; Annila I; Poole J; Andre C; Frew A
    J Allergy Clin Immunol; 2004 Oct; 114(4):831-7. PubMed ID: 15480323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiallergen immunotherapy for allergic rhinitis and asthma.
    Nelson HS
    J Allergy Clin Immunol; 2009 Apr; 123(4):763-9. PubMed ID: 19217653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sublingual immunotherapy.
    Esch RE
    Curr Opin Otolaryngol Head Neck Surg; 2008 Jun; 16(3):260-4. PubMed ID: 18475082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunotherapy.
    Osguthorpe JD
    Curr Opin Otolaryngol Head Neck Surg; 2010 Jun; 18(3):206-12. PubMed ID: 20389246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sublingual immunotherapy for children: Are we there yet? Defining its role in clinical practice.
    Campbell DE
    Paediatr Respir Rev; 2009 Jun; 10(2):69-74; quiz 74. PubMed ID: 19410205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sublingual immunotherapy is not always a safe alternative to subcutaneous immunotherapy.
    Cochard MM; Eigenmann PA
    J Allergy Clin Immunol; 2009 Aug; 124(2):378-9. PubMed ID: 19541352
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.